Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Show other versions (1)

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...

Full description

Bibliographic Details
Main Authors: Bimbo Diaz, Alejandro, Chow, Jeremy, Fan, Kee Hoo, Kok, Wei Koh, Chin, Gary Keong Lee, Wee, Siong Teo, Venketasubramanian, Narayanaswamy, Chun, Chieh Wang, Mehta, Radhika
Format: Article
Language:English
Published: Bioexcel Publishing 2023
Online Access:http://psasir.upm.edu.my/id/eprint/107426/1/107426.pdf

Similar Items

Similar Items